Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

36 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Biochemical characterization of nuclear pore complex protein gp210 oligomers.
Favreau C, Bastos R, Cartaud J, Courvalin JC, Mustonen P. Favreau C, et al. Eur J Biochem. 2001 Jul;268(14):3883-9. doi: 10.1046/j.1432-1327.2001.02290.x. Eur J Biochem. 2001. PMID: 11453980
This nucleoporin contains a large cisternal N-terminal domain, a short C-terminal cytoplasmic tail, and a single transmembrane segment. ...
This nucleoporin contains a large cisternal N-terminal domain, a short C-terminal cytoplasmic tail, and a single transmembrane segmen …
Expression of lamin A mutated in the carboxyl-terminal tail generates an aberrant nuclear phenotype similar to that observed in cells from patients with Dunnigan-type partial lipodystrophy and Emery-Dreifuss muscular dystrophy.
Favreau C, Dubosclard E, Ostlund C, Vigouroux C, Capeau J, Wehnert M, Higuet D, Worman HJ, Courvalin JC, Buendia B. Favreau C, et al. Exp Cell Res. 2003 Jan 1;282(1):14-23. doi: 10.1006/excr.2002.5669. Exp Cell Res. 2003. PMID: 12490190
Autosomal dominantly inherited missense mutations in lamins A and C cause familial partial lipodystrophy of the Dunnigan-type (FPLD), and myopathies including Emery-Dreifuss muscular dystrophy (EDMD). ...
Autosomal dominantly inherited missense mutations in lamins A and C cause familial partial lipodystrophy of the Dunnigan-type (FPLD), …
Differentiation of C2C12 myoblasts expressing lamin A mutated at a site responsible for Emery-Dreifuss muscular dystrophy is improved by inhibition of the MEK-ERK pathway and stimulation of the PI3-kinase pathway.
Favreau C, Delbarre E, Courvalin JC, Buendia B. Favreau C, et al. Exp Cell Res. 2008 Apr 1;314(6):1392-405. doi: 10.1016/j.yexcr.2008.01.018. Epub 2008 Feb 6. Exp Cell Res. 2008. PMID: 18294630
Expression of a mutant lamin A that causes Emery-Dreifuss muscular dystrophy inhibits in vitro differentiation of C2C12 myoblasts.
Favreau C, Higuet D, Courvalin JC, Buendia B. Favreau C, et al. Mol Cell Biol. 2004 Feb;24(4):1481-92. doi: 10.1128/mcb.24.4.1481-1492.2004. Mol Cell Biol. 2004. PMID: 14749366 Free PMC article.
Autosomal dominantly inherited missense mutations in lamins A and C cause several tissue-specific diseases, including Emery-Dreifuss muscular dystrophy (EDMD) and Dunnigan-type familial partial lipodystrophy (FPLD). ...
Autosomal dominantly inherited missense mutations in lamins A and C cause several tissue-specific diseases, including Emery-Dreifuss …
A cyclopeptidic suicide substrate preferentially inactivates urokinase-type plasminogen activator.
Reboud-Ravaux M, Vilain AC, Boggetto N, Maillard J, Favreau C, Xie J, Mazaleyrat JP, Wakselman M. Reboud-Ravaux M, et al. Among authors: favreau c. Biochem Biophys Res Commun. 1991 Jul 15;178(1):352-9. doi: 10.1016/0006-291x(91)91821-s. Biochem Biophys Res Commun. 1991. PMID: 1829886
c[Arg-aB-(CH2+SCH3 phi)-Gly4] was designed and studied as a mechanism-based inactivator (suicide substrate) for plasminogen activators (u-PA and t-PA) and plasmin. ...The limiting first-order rate constant kinact and the apparent enzyme-inhibitor dissociation constant KI w
c[Arg-aB-(CH2+SCH3 phi)-Gly4] was designed and studied as a mechanism-based inactivator (suicide substrate) for plasminogen activator
Prevention of some types of inflammatory damage using AA 231-1, a fluorinated beta-lactam.
Reboud-Ravaux M, Vergely I, Maillard J, Favreau C, Kobaiter R, Joyeau R, Wakselman M. Reboud-Ravaux M, et al. Among authors: favreau c. Drugs Exp Clin Res. 1992;18(5):159-62. Drugs Exp Clin Res. 1992. PMID: 1490431
Protection of vascular basement membrane and microcirculation from elastase-induced damage with a fluorinated beta-lactam derivative.
Maillard JL, Favreau C, Vergely I, Reboud-Ravaux M, Joyeau R, Kobaiter R, Wakselman M. Maillard JL, et al. Among authors: favreau c. Clin Chim Acta. 1992 Dec 31;213(1-3):75-86. doi: 10.1016/0009-8981(92)90222-c. Clin Chim Acta. 1992. PMID: 1477989
Reaction of thrombin and proteinases of the fibrinolytic system with a mechanism-based inhibitor, 3,4-dihydro-3-benzyl-6-chloromethylcoumarin.
Mor A, Maillard J, Favreau C, Reboud-Ravaux M. Mor A, et al. Among authors: favreau c. Biochim Biophys Acta. 1990 Mar 29;1038(1):119-24. doi: 10.1016/0167-4838(90)90019-c. Biochim Biophys Acta. 1990. PMID: 2138500
Thrombin, plasmin and tissue plasminogen activator (one- and two-chain forms) were examined with respect to their reaction with the suicide substrate, 3,4-dihydro-3-benzyl-6-chloromethylcoumarin, at 4 degrees C. ...
Thrombin, plasmin and tissue plasminogen activator (one- and two-chain forms) were examined with respect to their reaction with the suicide …
36 results
Jump to page
Feedback